Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Banyu Aims to Boost Nu-Lotan's Market Share to 30%
January 12, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 12, 2004
- IMS Japan Aims to Become a Services-based Company: President Saeki
January 12, 2004
- ON THE MOVE
January 12, 2004
- Time to New Drug Approval Down Sharply Since Mid-90s: OPIR
January 12, 2004
- Test Kit to Be Developed to Predict Effects of Morphine
January 12, 2004
- BUSINESS NEWS IN BRIEF
January 12, 2004
- RA Patients Criticized as Selfish, Lazy: Wyeth Survey
January 12, 2004
- BULLETIN
January 12, 2004
- Pharmacokinetic Frequency Analysis Database Jointly Developed by PSC, JBIC
January 12, 2004
- Surprise-Free 2004 Predictions
December 29, 2003
- Sales of 350 OTC Drug Products to Be Deregulated
December 29, 2003
- Sales of Fujisawa's Funguard Well Ahead of Initial Forecast
December 29, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
December 29, 2003
- Sales of GE Pravastatin Having Difficulties: Elmed Eisai
December 29, 2003
- PRESS SEMINAR
December 29, 2003
- Kuraya Sanseido to Merge with ATOL, Everlth to Form MEDICEO
December 29, 2003
- DIAGNOSTIC NEWS IN BRIEF
December 29, 2003
- Wholesalers' Profits May Fall 30% This Fiscal Year: Mr Kimura of CR&C
December 29, 2003
- MEDICAL DEVICE NEWS IN BRIEF
December 29, 2003
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…